Leif W Ellisen

Massachusetts General Hospital

NIH Rank #5515
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#5,515
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 4 grants · National rank #5515.

Top grants by award amount

Leif W Ellisen's NIH grant portfolio, ranked by award amount.

  • 1R01CA294793-01R01
    Elucidating resistance mechanisms and enhancing response to immune checkpoint blockade in central nervous system metastases from breast cancer
    $701.4K
    award amount
  • 5R01CA248923-03R01
    Subclonal heterogeneity and outcome disparities in Triple-Negative Breast Cancer among African Americans
    $547.4K
    award amount
  • 5R01CA260890-03R01
    Synergistic combinatorial DNA damage response/repair inhibition and Sacituzumab Govitecan in triple-negative breast cancer
    $531.8K
    award amount
  • 5R21CA284602-02R21
    Landscape and characterization of promoter mutations driving triple-negative breast cancer
    $188K
    award amount

Affiliation

Institutions that have administered grants for Leif W Ellisen.

Affiliated with Massachusetts General Hospital (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5515